logo-loader
HealthCannabis
viewZoetic International PLC

Zoetic's Nick Tulloch discusses new products, OTC listing and ambitious growth plans

Zoetic International's (LON:ZOE) Nick Tulloch sat down with Proactive London's Andrew Scott for an extended discussion on the firm's performance to date since its refocus on the CBD market and what's planned in the coming weeks and months.

''The really exciting part is that we're moving into cosmetics, at the end of November we should have a line of four cosmetics - a hand cream, a night cream, a facial serum and a lip balm - all high quality products in line with the rest of the brand with CBD included''.

Tulloch also discusses the recently announced share option scheme for its staff as well as what's happening with their OTC listing.

Quick facts: Zoetic International PLC

Price: 8.05 GBX

LSE:ZOE
Market: LSE
Market Cap: £11.92 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zoetic International PLC named herein, including the promotion by the Company of Zoetic International PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Zoetic International's Nick Tulloch updates as it begins trading on the OTC

Zoetic International PLC's (LON:ZOE) Nick Tulloch speaks to Proactive London's Andrew Scott after they began trading on the over-the-counter (OTC) market in the USA. Tulloch says the OTC market in the US should help to increase the liquidity of its shares.  No new ordinary shares were...

3 days, 12 hours ago

2 min read